|
1. BIOLOGIE
|
|
|
|
1.1 BIOLOGIE - GÉNOME
|
|
|
|
1.3 PRIX NOBEL
|
|
|
|
3.1 PRÉVENTION - TABAC
|
|
|
|
3.6 PRÉVENTION - ACTIVITÉ PHYSIQUE
|
|
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
|
4.15 DÉP., DIAG. & PRONO. - IMAGERIE
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.12.13 IMMUNOTHÉRAPIES - BIOMARQUEURS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
5.2 PHARMA
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
6.1 OBSERVATION
|
|
|
IUDs associated with lower ovarian cancer risk [Reuters]
|
|
|
|
|
|
Researchers examined data from 11 previous studies that tracked individual-level information on IUD (intrauterine device) use and ovarian cancer diagnosis for several hundred thousand women. Overall, women who used IUDs were 32% less likely than other women to develop ovarian cancer.
|
|
|
|
|
|